These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 32982484)
21. Evaluation of the clinical effectiveness of fluocinolone acetonide 190 µg intravitreal implant in diabetic macular edema: a comparison between study and fellow eyes. Currie CJ; Holden SE; Berni E; Owens DR Curr Med Res Opin; 2017 Oct; 33(sup2):19-31. PubMed ID: 28881143 [TBL] [Abstract][Full Text] [Related]
23. The Outcomes of Switching from Short- to Long-Term Intravitreal Corticosteroid Implant Therapy in Patients with Diabetic Macular Edema. Vaz-Pereira S; Castro-de-Sousa JP; Martins D; Prates Canelas J; Reis P; Sampaio A; Urbano H; Kaku P; Nascimento J; Marques-Neves C Ophthalmic Res; 2020; 63(2):114-121. PubMed ID: 31801148 [TBL] [Abstract][Full Text] [Related]
24. Case Series Investigating the Efficacy and Safety of Bilateral Fluocinolone Acetonide (ILUVIEN(®)) in Patients with Diabetic Macular Edema. Elaraoud I; Attawan A; Quhill F Ophthalmol Ther; 2016 Jun; 5(1):95-104. PubMed ID: 26885863 [TBL] [Abstract][Full Text] [Related]
25. Long-Term Follow-Up of Patient with Diabetic Macular Edema Receiving Fluocinolone Acetonide Intravitreal Implant. Bertelmann T; Schulze S Ophthalmol Ther; 2015 Jun; 4(1):51-8. PubMed ID: 25672501 [TBL] [Abstract][Full Text] [Related]
26. BILATERAL INTRAVITREAL 0.19-MG FLUOCINOLONE ACETONIDE IMPLANT FOR PERSISTENT NONDIABETIC CYSTOID MACULAR EDEMA AFTER VITRECTOMY. Ong SS; Walter SD; Chen X; Thomas AS; Finn AP; Fekrat S Retin Cases Brief Rep; 2021 May; 15(3):261-265. PubMed ID: 30015770 [TBL] [Abstract][Full Text] [Related]
27. Long-term Effects of Intravitreal 0.19 mg Fluocinolone Acetonide Implant on Progression and Regression of Diabetic Retinopathy. Wykoff CC; Chakravarthy U; Campochiaro PA; Bailey C; Green K; Cunha-Vaz J Ophthalmology; 2017 Apr; 124(4):440-449. PubMed ID: 28081945 [TBL] [Abstract][Full Text] [Related]
28. The efficacy and safety outcomes of the 0.19 mg fluocinolone acetonide implant after prior treatment with the 0.7 mg dexamethasone implant in patients with diabetic macular edema. Singh P; Chedid A; Deuchler SK; Kohnen T; Müller M; Koch FH Int Med Case Rep J; 2018; 11():265-269. PubMed ID: 30410411 [TBL] [Abstract][Full Text] [Related]
29. Case Series Investigating the Efficacy and Safety of Bilateral Fluocinolone Acetonide (ILUVIEN(®)) in Patients with Diabetic Macular Edema: 10 Eyes with 12 Months Follow-up. Elaraoud I; Quhill H; Quhill F Ophthalmol Ther; 2016 Jun; 5(1):105-9. PubMed ID: 27116231 [TBL] [Abstract][Full Text] [Related]
30. Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes. Coelho J; Malheiro L; Melo Beirão J; Meireles A; Pessoa B Clin Ophthalmol; 2019; 13():1751-1759. PubMed ID: 31571814 [TBL] [Abstract][Full Text] [Related]
31. The USER Study: A Chart Review of Patients Receiving a 0.2 µg/day Fluocinolone Acetonide Implant for Diabetic Macular Edema. Eaton A; Koh SS; Jimenez J; Riemann CD Ophthalmol Ther; 2019 Mar; 8(1):51-62. PubMed ID: 30560505 [TBL] [Abstract][Full Text] [Related]
32. Optical Coherence Tomography Biomarkers of Inflammation in Diabetic Macular Edema Treated by Fluocinolone Acetonide Intravitreal Drug-Delivery System Implant. Arrigo A; Capone L; Lattanzio R; Aragona E; Zollet P; Bandello F Ophthalmol Ther; 2020 Dec; 9(4):971-980. PubMed ID: 32914324 [TBL] [Abstract][Full Text] [Related]
34. Anterior migration of intravitreal fluocinolone acetonide (Iluvien®) implant in a pseudophakic eye with intact posterior capsule. Alzaabi M; Taguri AH; Elbarky A Am J Ophthalmol Case Rep; 2020 Dec; 20():100922. PubMed ID: 32995665 [TBL] [Abstract][Full Text] [Related]
35. Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN Adán A; Cabrera F; Figueroa MS; Cervera E; Ascaso FJ; Udaondo P; Abraldes M; Reyes MÁ; Pazos M; Pessoa B; Armadá F Clin Ophthalmol; 2020; 14():2091-2107. PubMed ID: 32801618 [TBL] [Abstract][Full Text] [Related]
36. Patterns of retinal thickness prior to and following treatment with fluocinolone acetonide 190 µg intravitreal implant for diabetic macular edema. Currie CJ; Holden SE; Owens DR Curr Med Res Opin; 2017 Oct; 33(sup2):33-43. PubMed ID: 28881150 [TBL] [Abstract][Full Text] [Related]
37. Economic evaluation of a fluocinolone acetonide intravitreal implant for patients with DME based on the FAME study. Cutino A; Green K; Kendall R; Moore PT; Zachary C Am J Manag Care; 2015 Jan; 21(4 Suppl):S63-72. PubMed ID: 25734663 [TBL] [Abstract][Full Text] [Related]